Mitochondria: a pathogenic paradigm in hypertensive renal disease.
From the Divisions of Nephrology and Hypertension (A.E., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, MN.
Alfonso
A
Eirin
From the Divisions of Nephrology and Hypertension (A.E., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, MN.
Amir
A
Lerman
From the Divisions of Nephrology and Hypertension (A.E., L.O.L.) and Cardiovascular Diseases (A.L., L.O.L.), Mayo Clinic, Rochester, MN. Lerman.Lilach@Mayo.Edu.
Lilach O
LO
Lerman
D000818:Animals; D017209:Apoptosis; D003251:Constriction, Pathologic; D004272:DNA, Mitochondrial / Q000235:genetics; D005355:Fibrosis; D050259:Genes, Mitochondrial; D020022:Genetic Predisposition to Disease; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology* / Q000235:genetics / Q000378:metabolism; D006978:Hypertension, Renovascular / Q000378:metabolism; D017379:Hypertrophy, Left Ventricular / Q000235:genetics; D007511:Ischemia / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply / Q000473:pathology; D008928:Mitochondria / Q000502:physiology*; D018384:Oxidative Stress; D017382:Reactive Oxygen Species / Q000378:metabolism; D015424:Reperfusion; D020521:Stroke / Q000235:genetics
D004272:DNA, Mitochondrial; D017382:Reactive Oxygen Species